The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Selective Janus kinase inhibitors come of age
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These first-generation JAK inhibitors target multiple JAKs and are therefore referred to as pan-JAK inhibitors”
From Targeting Interleukin-6 Signaling in Clinic (2019) · cites this paper as O’Shea and Gadina, 2019
Citations
Cites
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 590
Genovese, M. C., Fleischmann, R., Combe, B., Hall, S., Rubbert-Roth, A., Zhang, Y., Zhou, Y., Mohamed, M.-E. F., Meerwein, S., & Pangan, A. L. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31116-4 · Cited by 422
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
Papp, K., Gordon, K., Thaçi, D., Morita, A., Gooderham, M., Foley, P., Girgis, I. G., Kundu, S., & Banerjee, S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806382 · Cited by 420
Burmester, G. R., Kremer, J. M., Van den Bosch, F., Kivitz, A., Bessette, L., Li, Y., Zhou, Y., Othman, A. A., Pangan, A. L., & Camp, H. S. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31115-2 · Cited by 373
van der Heijde, D., Baraliakos, X., Gensler, L. S., Maksymowych, W. P., Tseluyko, V., Nadashkevich, O., Abi-Saab, W., Tasset, C., Meuleners, L., Besuyen, R., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32463-2 · Cited by 242
Mease, P., Coates, L. C., Helliwell, P. S., Stanislavchuk, M., Rychlewska-Hanczewska, A., Dudek, A., Abi-Saab, W., Tasset, C., Meuleners, L., Harrison, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32483-8 · Cited by 196
Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs
Gadina, M., Johnson, C., Schwartz, D. M., Bonelli, M. M., Hasni, S., Kanno, Y., Changelian, P. S., Laurence, A. D. J., & O’Shea, J. J. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ri0218-084r · Cited by 164
Self-citationLung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma
Dengler, H. S., Wu, X., Peng, I., Rinderknecht, C. H., Kwon, Y. C., Suto, E., Kohli, P. B., Liimatta, M. B., Barrett, K., Lloyd, J., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao2151 · Cited by 33
A Case Series on Patients on Tofacitinib in Combination With a Biologic
Barroso, N. S., Miller, E. Z., & Fürst, D. E. (2017) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000663 · Cited by 28
Cited by
Targeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Metadata
- Authors
- O’Shea, J. J., & Gadina, M.
- Venue
- Nature Reviews Rheumatology
- Published
- 2019-01-08
- Volume
- 15
- Issue
- 2
- Pages
- 74-75
- ISSN
- 1759-4790
- 1759-4804
- Cited by
- 68
- References
- 9
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Selective Janus kinase inhibitors come of age. https://app.cochat.ai/papers/10.1038/s41584-018-0155-9
- The paper
- O’Shea, J. J., & Gadina, M. (2019). Selective Janus kinase inhibitors come of age. Nature Reviews Rheumatology. https://doi.org/10.1038/s41584-018-0155-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
